Cargando…
ncDRMarker: a computational method for identifying non-coding RNA signatures of drug resistance based on heterogeneous network
BACKGROUND: Drug resistance is the primary cause of failure in the treatment of cancer. Identifying signatures of chemoresistance will help to overcome this problem. Current drug resistance studies focus on protein-coding genes and ignore non-coding RNAs (ncRNAs), rendering it a challenging task to...
Autores principales: | Yang, Haixiu, Xu, Yanjun, Shang, Desi, Shi, Hongbo, Zhang, Chunlong, Dong, Qun, Zhang, Yizheng, Bai, Ziyi, Cheng, Shujun, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723624/ https://www.ncbi.nlm.nih.gov/pubmed/33313140 http://dx.doi.org/10.21037/atm-20-603 |
Ejemplares similares
-
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019) -
Characterizing heterogeneity of non‐small cell lung tumour microenvironment to identify signature prognostic genes
por: Mi, Kai, et al.
Publicado: (2020) -
LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies
por: Xu, Yanjun, et al.
Publicado: (2017) -
The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017) -
Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015)